{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:54:35Z","timestamp":1775001275359,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Optometry - Journal of the American Optometric Association"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.optm.2010.02.011","type":"journal-article","created":{"date-parts":[[2010,7,9]],"date-time":"2010-07-09T08:18:55Z","timestamp":1278663535000},"page":"437-449","source":"Crossref","is-referenced-by-count":15,"title":["Ocular manifestations of Fabry disease within in a single kindred"],"prefix":"10.1016","volume":"81","author":[{"given":"Albert M.","family":"Morier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Minteer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Tyszko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"McCann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Virginia","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marsha F.","family":"Browning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.optm.2010.02.011_bib1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2133.1898.tb16317.x","article-title":"A case of \u201cangiokeratoma.\u201d","volume":"10","author":"Anderson","year":"1898","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.optm.2010.02.011_bib2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF01986897","article-title":"A contribution to the understanding of modular hemorrhagic purpura","volume":"43","author":"Fabry","year":"1898","journal-title":"Arch Dermatol Syphilis"},{"key":"10.1016\/j.optm.2010.02.011_bib3","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1542\/peds.2008-0635","article-title":"Lysosomal storage disorders in the newborn","volume":"123","author":"Staretz-Chacham","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.optm.2010.02.011_bib4","series-title":"The metabolic and molecular bases of inherited disease","article-title":"alpha-Galactosidase A deficiency: Fabry disease","author":"Desnick","year":"2001"},{"key":"10.1016\/j.optm.2010.02.011_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset Fabry disease revealed by newborn screening","volume":"79","author":"Spada","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.optm.2010.02.011_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10897-007-9128-x","article-title":"Diagnosis of Fabry disease via analysis of family history","volume":"17","author":"Laney","year":"2008","journal-title":"J Genet Couns"},{"key":"10.1016\/j.optm.2010.02.011_bib7","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","article-title":"Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency","volume":"276","author":"Brady","year":"1967","journal-title":"N Engl J Med"},{"key":"10.1016\/j.optm.2010.02.011_bib8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/jmg.2005.036327","article-title":"Natural history of Fabry disease in females in the Fabry Outcome Survey","volume":"43","author":"Deegan","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/j.optm.2010.02.011_bib9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.md.0000178976.62537.6b","article-title":"The relationship of vascular glycolipid storage to clinical manifestations of Fabry disease: a cross-sectional study of a large cohort of clinically affected heterozygous women","volume":"84","author":"Gupta","year":"2005","journal-title":"Medicine"},{"key":"10.1016\/j.optm.2010.02.011_bib10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ymgme.2007.09.013","article-title":"Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry","volume":"93","author":"Wilcox","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.optm.2010.02.011_bib11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/GIM.0b013e31802d8321","article-title":"Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life","volume":"9","author":"Wang","year":"2007","journal-title":"Genet Med"},{"key":"10.1016\/j.optm.2010.02.011_bib12","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","article-title":"Fabry's disease","volume":"372","author":"Zarate","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.optm.2010.02.011_bib13","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1001\/jama.1978.03290070049015","article-title":"Eye findings in the diagnosis of Fabry's disease. Patients with renal failure","volume":"240","author":"Bloomfield","year":"1978","journal-title":"JAMA"},{"key":"10.1016\/j.optm.2010.02.011_bib14","first-page":"195","article-title":"Fabry disease: ocular manifestations","volume":"12","author":"Franceschetti","year":"1976","journal-title":"Birth Defects Orig Artic Ser"},{"key":"10.1016\/j.optm.2010.02.011_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000076846","article-title":"Results of an ophthalmologic screening programme for identification of cases with Anderson-Fabry disease","volume":"218","author":"Hauser","year":"2004","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.optm.2010.02.011_bib16","first-page":"347","article-title":"Tortuosities of retinal and conjunctival vessels in lysosomal storage diseases","volume":"18","author":"Libert","year":"1982","journal-title":"Birth Defects Orig Artic Ser"},{"key":"10.1016\/j.optm.2010.02.011_bib17","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ajo.2005.11.053","article-title":"Corneal and conjunctival manifestations in Fabry disease: in vivo confocal microscopy study","volume":"141","author":"Mastropasqua","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.optm.2010.02.011_bib18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1442-9071.2005.00990.x","article-title":"Ophthalmological manifestations of Fabry disease: a survey of patients at the Royal Melbourne Fabry Disease Treatment Centre","volume":"33","author":"Nguyen","year":"2005","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.optm.2010.02.011_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1076\/opge.24.3.129.15609","article-title":"Ocular manifestations in Fabry disease: a survey of 32 hemizygous male patients","volume":"24","author":"Orssaud","year":"2003","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.optm.2010.02.011_bib20","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.survophthal.2008.04.005","article-title":"Ocular features of Fabry disease: diagnosis of a treatable life-threatening disorder","volume":"53","author":"Samiy","year":"2008","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.optm.2010.02.011_bib21","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1001\/archopht.1979.01020010327008","article-title":"The ocular manifestations in Fabry's disease","volume":"97","author":"Sher","year":"1979","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.optm.2010.02.011_bib22","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/bjo.2006.100602","article-title":"Ocular manifestations of Fabry's disease: data from the Fabry Outcome Survey","volume":"91","author":"Sodi","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.optm.2010.02.011_bib23","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/archopht.1965.00970040762005","article-title":"Fabry's disease. Its ocular manifestations","volume":"74","author":"Spaeth","year":"1965","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.optm.2010.02.011_bib24","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0140-6736(00)03554-6","article-title":"Anderson-Fabry's disease: alpha-galactosidase deficiency","volume":"357","author":"Peters","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.optm.2010.02.011_bib25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.optm.2005.12.002","article-title":"Acute onset of halos and glare: bilateral corneal epithelial edema with cystic eruptions\u2014atypical presentation of amiodarone keratopathy","volume":"77","author":"Dovie","year":"2006","journal-title":"Optometry"},{"key":"10.1016\/j.optm.2010.02.011_bib26","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00417-008-0962-9","article-title":"The microstructure of cornea verticillata in Fabry disease and amiodarone-induced keratopathy: a confocal laser-scanning microscopy study","volume":"247","author":"Falke","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.optm.2010.02.011_bib27","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey","volume":"34","author":"Mehta","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.optm.2010.02.011_bib28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s10545-007-0521-2","article-title":"Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry","volume":"30","author":"Eng","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.optm.2010.02.011_bib29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A\u2013replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.optm.2010.02.011_bib30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1001\/archopht.117.1.14","article-title":"Corneal thickness in ocular hypertension, primary open-angle glaucoma, and normal tension glaucoma","volume":"117","author":"Copt","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.optm.2010.02.011_bib31","first-page":"23","article-title":"Central corneal thickness of Caucasians and African Americans in glaucomatous and nonglaucomatous populations","volume":"119","author":"La Rosa","year":"2001","journal-title":"Arch Ophthalmology"},{"key":"10.1016\/j.optm.2010.02.011_bib32","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/jmg.40.8.e103","article-title":"Fabry disease: molecular studies in Italian patients and X inactivation analysis in manifesting carriers","volume":"40","author":"Morrone","year":"2003","journal-title":"J Med Genet"},{"key":"10.1016\/j.optm.2010.02.011_bib33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/08035320510028760","article-title":"Vascular complications of Fabry disease: enzyme replacement and other therapies","volume":"94","author":"Hughes","year":"2005","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.optm.2010.02.011_bib34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000310318","article-title":"Ischemic optic neuropathy in a female carrier with Fabry's disease","volume":"205","author":"Abe","year":"1992","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.optm.2010.02.011_bib35","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/archopht.1978.03910050421003","article-title":"Central retinal artery occlusion complicating Fabry's disease","volume":"96","author":"Sher","year":"1978","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.optm.2010.02.011_bib36","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2169\/internalmedicine.36.327","article-title":"High incidence of thrombosis in Fabry's disease","volume":"36","author":"Utsumi","year":"1997","journal-title":"Intern Med"},{"key":"10.1016\/j.optm.2010.02.011_bib37","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.38.11.769","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.optm.2010.02.011_bib38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000060196","article-title":"Clinical manifestation in female Fabry disease patients","author":"Whybra","year":"2001","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.optm.2010.02.011_bib39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cca.2009.02.008","article-title":"Effect of sample collection on alpha-galactosidase A enzyme activity measurements in dried blood spots on filter paper","author":"Olivova","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.optm.2010.02.011_bib40","first-page":"157","article-title":"Fabry disease: enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine and leukocytes","volume":"81","author":"Desnick","year":"1973","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.optm.2010.02.011_bib41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1096-7192(02)00012-4","article-title":"Fabry disease: 45 novel mutations in the alpha-galactosidase A gene causing the classical phenotype","volume":"76","author":"Shabbeer","year":"2002","journal-title":"Mol Genet Metab"}],"container-title":["Optometry - Journal of the American Optometric Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529183910002484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529183910002484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,9]],"date-time":"2018-12-09T18:26:18Z","timestamp":1544379978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1529183910002484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S1529183910002484"],"URL":"https:\/\/doi.org\/10.1016\/j.optm.2010.02.011","relation":{},"ISSN":["1529-1839"],"issn-type":[{"value":"1529-1839","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}